✨
AI Summary
- Sanofi acknowledges insulin shortage; oral therapy for T1D progresses.
- Potential for accurate, non-invasive CGM using sweat measured by a ring.
- Continued ADA conflict and a documentary highlighting T1D.
Diabetes Connections